Andrew Ritter
About Andrew Ritter
Andrew Ritter serves as the Chief Executive Officer of Koko Home and has extensive experience in healthcare technology and capital markets. He previously held leadership roles at Ritter Pharmaceuticals and Docbot, demonstrating his expertise in navigating complex financial landscapes and advancing therapeutic solutions.
Current Role at Koko Home
Andrew Ritter serves as the Chief Executive Officer at Koko Home, a position he has held since 2023. In this role, he focuses on leveraging artificial intelligence and large language models to improve remote monitoring and digital caregiver support for the aging population. His leadership aims to enhance the quality of care and support for individuals in need, addressing a critical area in healthcare technology.
Experience at Myosin Therapeutics Inc.
Since 2021, Andrew Ritter has been a Board Member at Myosin Therapeutics Inc. His tenure at the company spans three years, during which he has contributed to the strategic direction and governance of the organization. His involvement reflects his commitment to advancing therapeutic solutions within the biotechnology sector.
Leadership at Ritter Pharmaceuticals
Andrew Ritter held the position of President and Chief Executive Officer at Ritter Pharmaceuticals, Inc. from 2007 to 2020. During this period, he played a significant role in the company's growth and development, including spearheading its initial public offering on NASDAQ. His leadership was instrumental in navigating complex financial markets and advancing the clinical development phases of the company's therapeutic solutions.
Educational Background
Andrew Ritter has a strong educational background, having studied at The Wharton School, where he earned a Master of Business Administration (MBA) with a focus on Finance. He also holds a Bachelor of Arts degree in Political Science from the University of Southern California. Additionally, he attended Brentwood School, which laid the foundation for his academic and professional pursuits.
Previous Roles and Contributions
Before his current role at Koko Home, Andrew Ritter served as the Chief Executive Officer at Docbot from 2021 to 2022. He successfully led Docbot through its exit to Satisfai Health, showcasing his expertise in strategic business exits. Additionally, he served as an Entrepreneur in Residence at Khosla Ventures, contributing to the development of innovative healthcare solutions and demonstrating his extensive experience in capital markets and mergers and acquisitions.